SFA TherapeuticsRegulating the immune system to block cancer & autoimmune diseases

SFA Therapeutics: A New Paradigm for Treating Chronic Inflammatory Disease

Introduction

SFA Therapeutics is revolutionizing the treatment of chronic inflammatory diseases with a groundbreaking approach to drug discovery and development. Our innovative platform leverages endogenous biosynthetics to create safer, faster-to-market treatments.

Key Features

• Endogenous Biosynthetics: Utilizing natural substances derived from bacterial metabolites found in humans.
• No Genotoxicity: Ensuring safer treatments with minimal side effects.
• Faster Clinical Development: Accelerating the path from research to patient care.
• Lower R&D Costs: Reducing the financial burden of drug development.

Use Cases

• Autoimmune Diseases: Psoriasis
• Infectious Diseases: Cytokine Storm in COVID-19, Sepsis, Viral infections
• Liver Diseases: Hepatitis B, Steatosis, NASH, NAFLD
• Dermatology: Bullous Pemphigus (Rare Autoimmune Disease)
• Ophthalmology: Uveitis
• Oncology: Liver Cancer, Hepatocellular Carcinoma (HCC), Prevention of Cytokine Storm in CAR T Therapy

Pricing

Our pricing model is designed to be competitive and accessible, ensuring that innovative treatments are within reach for healthcare providers and patients alike. For detailed pricing information, please contact our sales team.

Teams

SFA Therapeutics is backed by a robust team of experts, including:

• Management Team and Founders: Visionaries driving the company's mission.
• Scientific Advisory Board: Leading scientists guiding our research and development.
• Business Advisory Team: Strategists ensuring sustainable growth and market reach.

Explore our pipeline and discover how SFA Therapeutics is setting new standards in the treatment of chronic inflammatory diseases.